Navigating New Advances Made in NSCLC in New York

January 31, 2019

We traveled to Syracuse, New York, for a State of the Science Summit on Advanced Non–Small Cell Lung Cancer, which focused on practice-change clinical trials in the space, as well as novel approaches to treatment with checkpoint inhibitors, targeted therapies, radiation, and minimally invasive surgery.

We headed to Syracuse, New York, for a State of the Science Summit on Advanced Non—Small Cell Lung Cancer. At the meeting, we spoke with the faculty of Upstate Medical University on practice-change clinical trials in the space, as well as novel approaches to treatment with checkpoint inhibitors, targeted therapies, radiation, and minimally invasive surgery. They also discussed the importance of screening for disease and highlighted the latest diagnostic and staging techniques.